Cubist Systematic Strategies’s Autolus Therapeutics AUTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$260K	Buy	159,408 +51,650	+48%	+$101K	﹤0.01%	2569
2025 Q2	$246K	Buy	+107,758	New	+$178K	﹤0.01%	2528
2024 Q2	–	Sell	-160	Closed	-$1.02K	–	2972
2024 Q1	$1.02K	Sell	160 -31,809	-99%	-$198K	﹤0.01%	3598
2023 Q4	$206K	Buy	+31,969	New	+$122K	﹤0.01%	2987
2023 Q2	–	Sell	-133,860	Closed	-$246K	–	3490
2023 Q1	$246K	Buy	133,860 +121,373	+972%	+$237K	﹤0.01%	3107
2022 Q4	$23.7K	Sell	12,487 -131	-1%	-$331	﹤0.01%	3980
2022 Q3	$27K	Sell	12,618 -8,869	-41%	-$26.3K	﹤0.01%	4204
2022 Q2	$61K	Buy	+21,487	New	+$65.4K	﹤0.01%	4063
2022 Q1	–	Sell	-26,854	Closed	-$139K	–	3550
2021 Q4	$139K	Buy	+26,854	New	+$161K	﹤0.01%	3126
2021 Q3	–	Sell	-20,244	Closed	-$134K	–	2956
2021 Q2	$134K	Sell	20,244 -5,730	-22%	-$35.6K	﹤0.01%	2672
2021 Q1	$149K	Buy	+25,974	New	+$192K	﹤0.01%	2558
2020 Q2	–	Sell	-245	Closed	-$1K	–	2389
2020 Q1	$1K	Buy	245 +160	+188%	+$1.48K	﹤0.01%	2119
2019 Q4	$1K	Buy	+85	New	+$1.11K	﹤0.01%	2387